Shantal Kash

As Relationship Manager at Camelot BioCapital, Shantal plays a key role in advancing the firm’s mission to support breakthrough technologies that extend human healthspan. She leads investor engagement, cultivates company communications, and connects aligned capital partners with opportunities across biotechnology, healthcare technology, and related sectors. Before joining Camelot, Shantal built a global career in international...

Ohad Shahar

Ohad Shahar is the Systems Manager at Camelot BioCapital, where he leads the design and implementation of internal systems that support the firm’s end-to-end investment process. He focuses on building scalable, structured workflows that enhance deal flow management, team coordination, and decision-making across the organization. Earlier in his career, Ohad served as Head of Medicine...

Dr. Greg Kunis

Dr. Kunis is a Research Analyst at Camelot BioCapital with a Doctor of Osteopathic Medicine degree from Nova Southeastern University and a Masters in Medical Education. Currently completing a general surgery residency, he brings a robust clinical foundation to his role. He is also pursuing a post-doctoral fellowship in the Clinical Trials Department at a...

Cedrick James Del Rosario

Cedrick is a Certified Public Accountant (CPA) with over 11 years of professional experience, specializing in accounting, tax, and financial management. Cedrick began his career as an auditor at PwC and has since held various roles including accounting manager, controller, tax consultant, bookkeeper, and market researcher in several multinational organizations. He has a strong command...

Dr. Esteban Pombo Villar, Ph.D

Dr. Pombo-Villar is currently the CTO of TargImmune Therapeutics AG in Switzerland. He held the post of CEO position from its seed stage in 2017 until August 2021. Under his leadership, the company developed the innovative targeted immunooncology platform and its lead project into IND-enabling studies, established the operations in Basel, and raised over CHF...

Dr. Duane Mitchell, M.D., Ph.D

Dr. Mitchell is Co-Founder, President, and Chairman of iOncologi, Inc., a biotechnology ‘spinout’ company from the University of Florida (UF) specializing in immuno-oncology. Dr. Mitchell is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery at UF. He serves as Director of the UF Clinical Translational Science Institute (CTSI) and Co-Director...

Scroll to top